[{"address1": "1177 Avenue of the Americas", "address2": "5th floor", "city": "New York", "state": "NY", "zip": "10036", "country": "United States", "phone": "332 216 1147", "website": "https://sunshinebiopharma.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Sunshine Biopharma, Inc., a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications. Sunshine Biopharma, Inc. is headquartered in New York, New York.", "fullTimeEmployees": 44, "companyOfficers": [{"maxAge": 1, "name": "Dr. Steve N. Slilaty Ph.D.", "age": 71, "title": "CEO, President & Chairman", "yearBorn": 1952, "fiscalYear": 2023, "totalPay": 640000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Camille  Sebaaly", "age": 64, "title": "CFO & Secretary", "yearBorn": 1959, "fiscalYear": 2023, "totalPay": 695000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Abderrazzak  Merzouki", "age": 59, "title": "Chief Science Officer & Director", "yearBorn": 1964, "fiscalYear": 2023, "totalPay": 340000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Marc  Beaudoin", "age": 56, "title": "Chief Operating Officer", "yearBorn": 1967, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Malek  Chamoun", "age": 38, "title": "Chief Development Officer", "yearBorn": 1985, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert G. Ferreira", "age": 61, "title": "President of Sunshine Bio Investments Inc", "yearBorn": 1962, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.8023, "open": 0.7984, "dayLow": 0.7337, "dayHigh": 0.7984, "regularMarketPreviousClose": 0.8023, "regularMarketOpen": 0.7984, "regularMarketDayLow": 0.7337, "regularMarketDayHigh": 0.7984, "trailingPE": 0.0013393501, "forwardPE": 0.07427427, "volume": 2106245, "regularMarketVolume": 2106245, "averageVolume": 3041496, "averageVolume10days": 3875480, "averageDailyVolume10Day": 3875480, "bid": 0.7364, "ask": 0.748, "bidSize": 800, "askSize": 300, "marketCap": 14057264, "fiftyTwoWeekLow": 0.7337, "fiftyTwoWeekHigh": 67.0, "priceToSalesTrailing12Months": 0.52570605, "fiftyDayAverage": 4.03424, "twoHundredDayAverage": 21.80806, "currency": "USD", "enterpriseValue": -2751613, "profitMargins": -0.15286, "floatShares": 18161485, "sharesOutstanding": 18945100, "sharesShort": 284508, "sharesShortPriorMonth": 7066, "sharesShortPreviousMonthDate": 1711584000, "dateShortInterest": 1714435200, "sharesPercentSharesOut": 0.2861, "heldPercentInsiders": 0.00496, "heldPercentInstitutions": 0.0049900003, "shortRatio": 0.06, "shortPercentOfFloat": 0.2984, "impliedSharesOutstanding": 18945100, "bookValue": 24.943, "priceToBook": 0.029747823, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -4087415, "trailingEps": 554.0, "forwardEps": 9.99, "lastSplitFactor": "1:100", "lastSplitDate": 1713312000, "enterpriseToRevenue": -0.103, "enterpriseToEbitda": 0.663, "52WeekChange": -0.9874024, "SandP52WeekChange": 0.25262225, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "SBFM", "underlyingSymbol": "SBFM", "shortName": "Sunshine Biopharma Inc.", "longName": "Sunshine Biopharma, Inc.", "firstTradeDateEpochUtc": 1644935400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "7909c686-ce8d-3dd2-8c10-62221258e4a3", "messageBoardId": "finmb_78729055", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.742, "targetHighPrice": 15.0, "targetLowPrice": 15.0, "targetMeanPrice": 15.0, "targetMedianPrice": 15.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 17434208, "totalCashPerShare": 0.92, "ebitda": -4149852, "totalDebt": 612366, "quickRatio": 3.101, "currentRatio": 4.413, "totalRevenue": 26739780, "debtToEquity": 2.467, "revenuePerShare": 76.716, "returnOnAssets": -0.09142, "returnOnEquity": -0.18475, "freeCashflow": -10046124, "operatingCashflow": -10110164, "revenueGrowth": 0.541, "grossMargins": 0.33154, "ebitdaMargins": -0.15519, "operatingMargins": -0.17909999, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-05-24"}]